Clinical Trials Directory

In this study, participants will use eye drops in one eye six times each day for eight weeks. The eye drops will contain either the study medicine called cenegermin or a liquid with no medicine. Participants will write down each time they use the eye drops in a study diary. After the first eight weeks, the doctor will decide which group each person will be in for the next part of the study. During this next period, participants will continue using eye drops for another eight weeks. After that, they will use standard eye drops without preservatives for twenty four weeks.

24-month enrollment period and up to 5 years of follow-up.

In this study, everyone will receive a medicine called ianalumab that is given through a vein. People will get this treatment once every four weeks for four doses. During this time, they will come to the clinic each week to have blood tests to check their platelet levels. They will also take another medicine chosen by the study doctor to help increase platelets. After the last dose of the study medicine, participants will continue to have weekly blood checks for 16 weeks. After that, they will have blood checks once a month for one year. The goal is to closely watch how their blood counts change over time and see how well the treatment works.

We are doing this study to compare two commonly used treatment choices for early-stage breast cancer in premenopausal women. We want to know if either option is a better choice than the other.

We are doing this study to find out if a blood test for circulating tumor DNA (ctDNA) can provide information that might help doctors figure out the most appropriate therapy for patients with colon cancer after they have surgery.

We are doing this study to find out if adding radiation therapy has any positive benefit when it is added to the usual treatment regimen for this form of cancer.

Group 1: People in this group will get the usual chemotherapy and radiation treatment for this cancer. They will have radiation 5 days a week for 4 to 5 weeks. That means about 20 treatments in total. Group 2: People in this group will get the usual chemotherapy and a new way of giving radiation. This way uses fewer treatments with a higher dose. They will have radiation up to 2 days a week for up to 4 weeks. That means about 5 treatments in total.